1. Home
  2. LFMD vs ENGN Comparison

LFMD vs ENGN Comparison

Compare LFMD & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.48

Market Cap

330.5M

Sector

Health Care

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$9.34

Market Cap

379.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
ENGN
Founded
1994
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
330.5M
379.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LFMD
ENGN
Price
$3.48
$9.34
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$10.22
$22.71
AVG Volume (30 Days)
1.1M
283.0K
Earning Date
11-17-2025
12-22-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,091,814.00
N/A
Revenue This Year
$13.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.78
N/A
52 Week Low
$3.18
$2.65
52 Week High
$15.84
$11.14

Technical Indicators

Market Signals
Indicator
LFMD
ENGN
Relative Strength Index (RSI) 38.82 62.85
Support Level $3.21 $7.57
Resistance Level $3.45 $8.47
Average True Range (ATR) 0.18 0.69
MACD 0.06 0.07
Stochastic Oscillator 44.70 78.18

Price Performance

Historical Comparison
LFMD
ENGN

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: